Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, E. S.
Right arrow Articles by Stegink, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, E. S.
Right arrow Articles by Stegink, L. D.

Propargylglycine Infusion Effects on Tissue Glutathione Levels, Plasma Amino Acid Concentrations and Tissue Morphology in Parenterally-Fed Growing Rats1 ,2

El Soon Cho3, Jane Hovanec-Brown, Robert J. Tomanek* and Lewis D. Stegink{dagger}

Department of Home Economics * Department of Anatomy {dagger} Departments of Pediatrics and Biochemistry, The University of Iowa, Iowa City, IA 52242

Amino acid solutions currently used for total parenteral nutrition (TPN) contain little cysteine or cystine. Some premature human infants have low liver activities of {gamma}-cystathionase and presumably require preformed cysteine or cystine. Growing animals tend to have higher liver {gamma}-cystathionase activity, which makes them unsuitable as models to study effects of CSH precursors. Because propargylglycine (PPG) inhibits {gamma}-cystathionase specifically, rats infused with PPG as part of a TPN regimen were evaluated as a potential model. Two groups of rats (120–160 g) were infused for 15 d with TPN regimens, one without and one with PPG (40 µmol/d). A third group received the TPN-control regimen, with methionine added at toxic levels. Propargylglycine treatment significantly decreased plasma cystine and taurine concentrations and significantly increased plasma cystathionine concentration without affecting methionine concentration. Propargylglycine treatment significantly decreased brain, muscle, liver, intestine and stomach glutathione concentration without affecting erythrocyte or heart glutathione concentrations. Electron microscopic examination showed no abnormalities in heart and kidney of PPG-treated rats. Hepatocyte glycogen was lower in TPN-fed controls than in orally fed rats and was further reduced in TPN-PPG-fed animals. Growing rats infused with low doses of PPG show promise as an animal model to study a number of important issues concerning human sulfur amino acid metabolism.


KEY WORDS: • cysteine • cystine • parenteral • rats • propargylglycine

1 Supported by a grant-in-aid from the Nutrition Foundation.

2 These data were presented in preliminary form at the 1982 meeting of the American Institute of Nutrition [Cho, E. S., Hovanec-Brown, J., Tomanek, R. & Stegink, L. D. (1982) Effect of propargylglycine (PG) on tissue morphology, tissue glutathione (GSH) levels, and plasma amino acid levels in parenterally (TPN)-fed growing rats. Fed. Proc. 41: 540 (abs. 1579)].

3 Present address: 404 Food Science Building, Food and Nutrition, Texas Tech University, Lubbock, TX 79409.

Manuscript received 25 July 1990. Revision accepted 24 October 1990.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 1991 by American Society for Nutrition